N0018926RB011 - Drug Demand Reduction Program, Fentanyl/Norfentanyl Immunoassay Reagent Kits

The Department of the Navy, NAVSUP FLT LOG CTR Norfolk, is issuing solicitation N0018926RB011 to procure Fentanyl/Norfentanyl Immunoassay Reagent Kits for the Drug Demand Reduction Program. These Food & Drug Administration and Quality Management documented kits must be compatible with existing Beckman Coulter AU5800 series systems to detect fentanyl and norfentanyl in human urine samples. The requirement covers a five-year ordering period with an estimated capacity to accommodate up to 500,000 tests per month.

This procurement is classified under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing and PSC 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS. There is no set-aside designated for this action, identified as set-aside NONE (NONE). Performance will take place in Portsmouth, Virginia, and the primary point of contact is Contracting Specialist Austin Waller.

Responses to this combined synopsis/solicitation are due by June 26, 2026. The notice includes four attachments: a Statement of Work for the testing kits, a Past Performance Information Form, and two versions of the solicitation document dated May 26 and May 27, 2026.